On May 30th, international experts and politicians gathered in Leiden to discuss global health issues. Lively discussions were held on matters concerning equal worldwide access to vaccines and diversity within clinical research. New scientific insights were also shared, including on vaccine response differences between African and European populations. The daily conclusion was clear: global collaboration and innovative research is key to solving the greatest health challenges of our time.
During the Global Impact in Health Symposium forces were joined with Leiden University, Health~Holland, Bristol Myers Squibb (BMS), Janssen, Philips and the Leiden Bio Science Park (LBSP). The aim was to bring together international experts and to stimulate new collaborations. Experts not only came from all over the world, but also from different branches, such as academia, politics, public or private sector.
This mix of high-level people and expert led to vivid discussion on the major challenges in global health(care). Read the full story here!
Wednesday, December 15th 2021, marks a special day as medical journal The Lancet Global Health published a new mixed-method study on mapping low-resource contexts to prepare for lung health interventions in four countries, conducted by the ‘FRESH AIR collaborators’. This international research group, led by the LUMC, found worryingly that chronic respiratory disease (CRD) often gets misinterpreted as an infection, especially as tuberculosis. The study found three themes to address that might prove pivotal for adequate implementation of interventions for CRD.
In the summer of 2021, the LUMC will host numerous summer schools on varying topics. All summer courses will be online due to COVID, making it possible for international students to join more easily!
During the Global Impact in Health Symposium, Dr. Emile Bienvenu, Director General of the Food and Drug Authority of Rwanda and Hans Schikan, PharmD, Topteam Member Dutch Topsector Life Sciences & Health (Health Holland, organizing partner of the symposium) and former Special Envoy for Vaccines will reflect on the COVID-19 pandemic till date and discuss how to create a better global ecosystem to generate more impact on patients. Hans Schikan shares his experience as Special Envoy for Vaccines and what he expects from the fireside chat with Dr. Emile Bienvenu.